Literature DB >> 26725092

Relaunching an old drug: the potential role of bexarotene in neurodegenerative diseases.

Javier Riancho1, Maria T Berciano2, Jose Berciano3, Miguel Lafarga2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26725092     DOI： 10.1007/s00415-015-8004-0

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

Review 1.  Role of retinoid signalling in the adult brain.

Authors:  Michelle A Lane; Sarah J Bailey
Journal:  Prog Neurobiol       Date:  2005-03       Impact factor: 11.685

2.  RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.

Authors:  Iliya Lefterov; Jonathan Schug; Anais Mounier; Kyong Nyon Nam; Nicholas F Fitz; Radosveta Koldamova
Journal:  Neurobiol Dis       Date:  2015-06-10       Impact factor: 5.996

3.  ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

Authors:  Paige E Cramer; John R Cirrito; Daniel W Wesson; C Y Daniel Lee; J Colleen Karlo; Adriana E Zinn; Brad T Casali; Jessica L Restivo; Whitney D Goebel; Michael J James; Kurt R Brunden; Donald A Wilson; Gary E Landreth
Journal:  Science       Date:  2012-02-09       Impact factor: 47.728

4.  Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Nicholas F Fitz; Andrea A Cronican; Iliya Lefterov; Radosveta Koldamova
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

5.  Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Ina Tesseur; Adrian C Lo; Anouk Roberfroid; Sofie Dietvorst; Bianca Van Broeck; Marianne Borgers; Harrie Gijsen; Diederik Moechars; Marc Mercken; John Kemp; Rudi D'Hooge; Bart De Strooper
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

6.  Response to comments on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Gary E Landreth; Paige E Cramer; Mitchell M Lakner; John R Cirrito; Daniel W Wesson; Kurt R Brunden; Donald A Wilson
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

7.  Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Karthikeyan Veeraraghavalu; Can Zhang; Sean Miller; Jasmin K Hefendehl; Tharinda W Rajapaksha; Jason Ulrich; Mathias Jucker; David M Holtzman; Rudolph E Tanzi; Robert Vassar; Sangram S Sisodia
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

8.  Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Authors:  Ashleigh R Price; Guilian Xu; Zoe B Siemienski; Lisa A Smithson; David R Borchelt; Todd E Golde; Kevin M Felsenstein
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

Review 9.  Bexarotene: a clinical review.

Authors:  Len T Farol; Kenneth B Hymes
Journal:  Expert Rev Anticancer Ther       Date:  2004-04       Impact factor: 4.512

10.  Compensatory Motor Neuron Response to Chromatolysis in the Murine hSOD1(G93A) Model of Amyotrophic Lateral Sclerosis.

Authors:  Javier Riancho; Maria Ruiz-Soto; Nuria T Villagrá; Jose Berciano; Maria T Berciano; Miguel Lafarga
Journal:  Front Cell Neurosci       Date:  2014-10-22       Impact factor: 5.505
View more
  2 in total

1.  Scaffold hopping from synthetic RXR modulators by virtual screening and de novo design.

Authors:  Daniel Merk; Francesca Grisoni; Lukas Friedrich; Elena Gelzinyte; Gisbert Schneider
Journal:  Medchemcomm       Date:  2018-06-06       Impact factor: 3.597

2.  Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms.

Authors:  Apirat Chaikuad; Julius Pollinger; Michael Rühl; Xiaomin Ni; Whitney Kilu; Jan Heering; Daniel Merk
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.